Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENACTIF trial of intravenous N-acetylcysteine in hemodialysis patients
2018-003232-80Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in chronic kidney disease (CKD), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Oct 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2018-003232-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003232-80.